benign or malignant.
The first case of ectopic ACTH syndrome was probably reported by Brown (1928) who described the case of a bearded woman with diabetes. At that time the author had no idea that ACTH existed. The discovery of ACTH, the development of an ACTH bioassay, and the pioneering work of Liddle's group eventually led to the identification of patients with Cushing's syndrome in whom ACTH was produced by so called 'non-endocrine' tumors. In the initial paper by Meador et al. (1962) most of these patients had lung tumors, the extracts of which contained bioactive ACTH. The concept of 'ectopie hormone secretion' was then bom. The detailed pathophysiological mechanism remains highly intriguing today, a third of a century later, even though remarkable progress has been made, essentially through the recent advances in molecular endocrinology and the unravelling of the details of the mechanism of ACTH biosynthesis.
Pro-opiomelanocortin (POMC) (Phifer et al. 1974) inescapably suggested that they derived from a common polypeptide precursor. The AtT-20 cell line which derives from a mouse pituitary tumor and secretes vast amounts of ACTH was used as a model to demonstrate the exist¬ ence of an HMW IR-ACTH material that was anti-ßend and anti-LPH antibodies (Bertagna et al. 1978) . Thus (Therrien & Drouin 1991) , whereas a single factor, Pit-l/GHF-1, plays a determinant role for GH and PRL gene expression (Bodner et al. 1988) (Therrien & Drouin 1991 ). Recently Therrien & Drouin ( 1993) (Texier et al. 1991 ) (Fig. 5 ). (Vieau etal. 1992 Ratter et al. 1980 , Stewart et al. 1994 or, on the contrary, abnormal fragments such as CLIP and human ßMSH5_22 may be generated (Orth et al. 1973 , Ratcliffe et al. 1973 , Bertagna et al. 1986 , Vieau et al. 1989 . Recent studies have shown that PC2 was specifically present in these tumors which contained CLIP and not in those which contained predomi¬ nantly ACTH (Vieau et al. 1994 ). This latter abnormality may diminish the tissue's ability to secrete authentic ACTH, the sole bioactive peptide in terms of steroidogenesis, and somehow protect the patients from the consequences of the tumor produc¬ tion; they also provide the investigator with subtle molecular clues that an ACTH-dependent Cushing's syndrome may originate from a non-pituitary source.
A frequent feature of the ectopie ACTH syndrome is a discrepant plasma LPH/ACTH ratio, which is unexpectedly high (Kuhn et al. 1989 (Fig. 6) (Picon etal. 1995 (Ray etal. 1994 ). It has also been claimed that overexpression of llß-hydroxysteroid dehydrogenase, an enzyme converting cortisol into its inactive metabolite corti¬ sone, might diminish the biological effects of endogenous glucocorticoids (Gaitan et al. 1992) .
These results raise the question of whether POMC is merely expressed by a set of non-specific factors that also pick up the POMC gene by virtue of some permissive chromatin structure in the vicinity of the gene. Thus SCCL lines which derive from highly malignant, poorly differentiated bronchial cancers may represent a specific and unusual situa¬ tion that is far from that in a normal pituitary.
In contrast with SCCLs, bronchial carcinoids are highly differentiated and rather indolent neuroendo¬ crine tumors which can also express the POMC gene and induce the ectopie ACTH syndrome. We have hypothesized that the mechanism of POMC gene transcription in these tumors is different and perhaps more related to the classic pituitary mechanism: in at an extremely high rate (Texier et al. 1991) . They can retain some glucocorticoid regulation (Suda et al. 1993 
